Hydrogel Patch for the Treatment of Eczema

• Status: Terminated
• Trial end date: 2012-07-01

Summary

The primary objective of this clinical study is to determine whether occlusion of triamcinolone 0.1% cream (TAC) with hydrogel patch improves its efficacy in treating eczema. A secondary objective is to determine whether eczema improves under occlusion with hydrogel patch alone, without TAC.

• Phase: N/A

Details

• Lead Sponsor: University of California, San Francisco
• Collaborators: Teikoku Pharma USA; Teikoku Pharma USA, Inc.
• Treatments: Triamcinolone; Triamcinolone Acetonide; Triamcinolone diacetate; Triamcinolone hexacetonide